Zobrazeno 1 - 3
of 3
pro vyhledávání: '"E. G. Arshanskaya"'
Autor:
A. D. Kulagin, E. A. Lukina, V. V. Ptushkin, M. P. Kostinov, E. G. Arshanskaya, T. N. Babaeva, T. I. Ksenzova, Z. T. Fidarova, M. V. Marchenko
Publikováno v:
Онкогематология, Vol 18, Iss 3, Pp 140-144 (2023)
On June 24, 2023, an Expert Council was held in St. Petersburg, during which leading experts in the field of hematology discussed current achievements and answered a number of unresolved issues of targeted therapy of paroxysmal nocturnal hemoglobinur
Externí odkaz:
https://doaj.org/article/7a0ccf75cd9245f48e4ac2e80b45a701
Autor:
S. V. Semochkin, E. G. Arshanskaya, O. D. Zakharov, A. N. Kotelnikova, S. S. Kulikova, E. V. Ovanesova, Yu. B. Kochkareva, V. L. Ivanova
Publikováno v:
Онкогематология, Vol 10, Iss 1, Pp 16-23 (2015)
Efficacy and safety results of rituximab and bendamustine combination (Scheme BR) in patients with relapsed and refractory chronic lymphocytic leukemia (CLL) are presented. From 01.2012 to 04.2013, the treatment was initiated in 43 patients (21 with
Externí odkaz:
https://doaj.org/article/dcd775da76264d68be7f28f9c505a29f
Autor:
V V PTUSHKIN, O Yu VINOGRADOVA, M M PANKRASHKINA, M V CHERNIKOV, E G ARSHANSKAYA, N E TKACHENKO
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 70-76 (2018)
Objective: To analyze the long-term efficacy and safety of ATR in adult patients with primary resistant ITP in real-world clinical practice. Materials and methods.The article contains long-term results analysis of ATR application under real clinical
Externí odkaz:
https://doaj.org/article/372d2ebdd3a4443cad148ea8ac23d597